In 2020, the COVID-19 pandemic suspended or delayed more than 230 of the 500 plus planned campaigns and continues to impact campaign planning and implementation in 2021. However, much has been learned from those that have continued or restarted campaigns that can be shared and used by other campaign platforms as well as applying tools, lessons, and effective practices to inform the roll out of the COVID-19 vaccines.
What approaches and tools have been successful in improving campaign effectiveness, efficiency and quality?
- What measures/metrics should be used to monitor and evaluate outcomes and whether campaigns are reaching “zero dose” and “never-treated” communities?
What lessons have been learned about how to plan and deliver health campaigns during the COVID-19 pandemic?
- Which of these new approaches or methods will continue to be practiced beyond the pandemic?
How can the lessons learned from existing campaign platforms and best practices, inform and support the planning and delivery of COVID-19 vaccines?
- What has been the impact of the COVID-19 vaccine rollout on campaigns for NTDs, polio, VPDs, malaria, VAS? (e.g. negative impacts due to workforce pulled to COVID vaccine delivery or positive impacts such as strengthening microplans, surveillance and other HIS, training, identification of hard to reach populations)